Esperion Therapeutics
ESPR
ESPR
164 hedge funds and large institutions have $458M invested in Esperion Therapeutics in 2022 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $426M → $458M (+$32M)
4.54% more ownership
Funds ownership: 95.15% → 99.69% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
164
Holding in Top 10
2
Calls
$50.2M
Puts
$14.2M
Top Buyers
| 1 | +$16.4M | |
| 2 | +$6.45M | |
| 3 | +$5.92M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$5.64M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$5.03M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$10.2M | |
| 3 | -$4.81M | |
| 4 |
Walleye Capital
New York
|
-$4.68M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.83M |